| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 10/04/2001 | CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 10/03/2001 | CN1315945A Nitrate salts of antihypertensive medicines |
| 10/03/2001 | CN1315873A Prevention/remedies for multiple organ failure |
| 10/03/2001 | CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates |
| 10/03/2001 | CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists |
| 10/03/2001 | CN1072219C Diazatropone, its production and use |
| 10/03/2001 | CN1072210C 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors |
| 10/03/2001 | CN1072209C Benzonitriles and benzofluorides |
| 10/02/2001 | US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them |
| 10/02/2001 | US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 10/02/2001 | US6297252 Treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and enhancement of memory. |
| 10/02/2001 | US6297239 Inhibitors of prenyl-protein transferase |
| 10/02/2001 | US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases |
| 10/02/2001 | CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| 09/27/2001 | WO2001070737A2 Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof |
| 09/27/2001 | WO2001070732A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070706A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 09/27/2001 | WO2001070232A1 Protease inhibitors |
| 09/27/2001 | WO2001017972A3 Novel herbicides |
| 09/27/2001 | US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives |
| 09/27/2001 | US20010025043 New pharmaceutical active compounds |
| 09/27/2001 | DE10014607A1 Production of asymmetric 4,6-bis(aryloxy)-pyrimidine derivatives comprises two stage reaction of 4,6-dichloro-pyrimidine with phenols using 1,4-diazabicyclo(2.2.2)octane in second reaction stage |
| 09/27/2001 | CA2404206A1 Protease inhibitors |
| 09/27/2001 | CA2400000A1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 09/26/2001 | EP1136474A1 1-Acetyl-5-bromo-4,6-dimethyl-indoline |
| 09/26/2001 | EP1136071A2 Use of glycogen phosphorylase inhibitors |
| 09/26/2001 | EP1135381A1 Eletriptan hydrobromide monohydrate |
| 09/26/2001 | EP1135370A2 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 09/26/2001 | EP1135131A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 09/26/2001 | EP0909271B1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 09/26/2001 | EP0795326B1 Ocular tension depressant |
| 09/26/2001 | CN1314815A Immunodulatory drug composition |
| 09/26/2001 | CN1071757C Pyrazol benzoyl derivatives |
| 09/26/2001 | CN1071754C Pyrimidinylpyrazole derivative |
| 09/26/2001 | CN1071753C 7-azabicyclo [2,2,1]-heptane and heptene derivatives as cholinergic receptor ligands |
| 09/25/2001 | US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294566 Imidazoline derivatives and uses thereof |
| 09/25/2001 | US6294565 Treatment of leukemia by administering a bisimidazole thiophene |
| 09/25/2001 | US6294561 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/25/2001 | US6294558 Antiinflammatory agents and prostaglantins |
| 09/25/2001 | US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294553 Method for treating ocular pain |
| 09/25/2001 | US6294551 N-linked sulfonamides of heterocyclic thioesters |
| 09/25/2001 | US6294542 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/25/2001 | US6294536 Triazine derivatives, their production and use |
| 09/25/2001 | US6294535 Uracil derivatives and antitumor effect potentiator and antitumor agent containing the same |
| 09/25/2001 | CA2029132C Sulphonylaminocarbonyltriazolinones having substituents which are bonded via sulphur |
| 09/22/2001 | CA2341344A1 Use of glycogen phosphorylase inhibitors |
| 09/20/2001 | WO2001068652A1 Condensed imidazoles as histamine h3 receptor ligands |
| 09/20/2001 | WO2001068614A2 5-substituted arylpyrimidines |
| 09/20/2001 | WO2001068612A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 09/20/2001 | WO2001068603A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 09/20/2001 | WO2001068585A1 Novel amide compounds |
| 09/20/2001 | WO2001068055A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 09/20/2001 | WO2001068047A2 Preparation containing quinoxaline derivatives |
| 09/20/2001 | US20010023295 By reacting a 3-((alkyl, alkoxy, phenyl or heteroaryl)carbonylamino)thiophene with a ketone in the presence of an acid and reducing the reaction mixture; agricultural fungicides |
| 09/20/2001 | US20010023250 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 09/20/2001 | DE10013318A1 Quinoxaline derivatives are used as photo-stable UV filters in cosmetic or pharmaceutical sunscreens for the hair or skin |
| 09/20/2001 | CA2403241A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 09/20/2001 | CA2373411A1 5-substituted arylpyrimidines |
| 09/19/2001 | EP1134213A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides |
| 09/19/2001 | EP1133490A1 Piperazinone derivatives |
| 09/19/2001 | EP1133488A1 Propanoic acid derivatives as integrin inhibitors |
| 09/19/2001 | EP1133483A1 Il-5 inhibiting 6-azauracil derivatives |
| 09/19/2001 | EP1133481A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133480A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133479A1 Quinoline and quinoxaline compounds |
| 09/19/2001 | EP1133477A1 Substituted benzimidazoles and their use as parp inhibitors |
| 09/19/2001 | EP1133293A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
| 09/19/2001 | CN1313854A Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 09/19/2001 | CN1313853A Oxindole derivatives as growth hormone releasers |
| 09/19/2001 | CN1313280A Benzheterocyclic derivatives |
| 09/19/2001 | CN1071331C Anti-helicobacter acyl derivatives of azolones |
| 09/19/2001 | CN1071330C Anti-helicobacter urea and thiourea derivatives of azolones |
| 09/18/2001 | US6291505 Pyrazole estrogen receptor agonist and antagonist |
| 09/18/2001 | US6291501 Specifically exemplified herein are dragmacidin f, topsentin d, and topsentin e, and their salts, analogs, and derivatives. |
| 09/18/2001 | US6291499 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
| 09/18/2001 | US6291485 Treatment of post-ptca restenosis |
| 09/18/2001 | US6291476 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 09/18/2001 | US6291457 Compounds having cytokine inhibitory activity |
| 09/18/2001 | US6291453 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/18/2001 | US6291452 Cholecystokinin antagonists. |
| 09/18/2001 | US6291451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 09/18/2001 | CA2236814C Quinoline and quinazoline compounds useful in therapy |
| 09/13/2001 | WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 09/13/2001 | WO2001066520A1 Indole derivatives, process for preparation of the same and use thereof |
| 09/13/2001 | WO2001066519A2 Method for preparing pyrimidone derivatives with antifungal activity |
| 09/13/2001 | WO2001066099A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 09/13/2001 | WO2000059886A3 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors |
| 09/13/2001 | US20010021719 2-phenyl-1- [4- (2-aminoethoxy) - benzyl] - indoles as estrogenic agents |
| 09/13/2001 | US20010021708 Acylurea compound containing imidazolidine ring |
| 09/13/2001 | CA2402174A1 Indole derivatives, process for preparation of the same and use thereof |
| 09/12/2001 | EP1132387A1 Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultura/horticultural bactericides |
| 09/12/2001 | EP1132379A1 Novel thiol derivatives, process for producing the same and utilization thereof |
| 09/12/2001 | EP1132086A2 Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure |
| 09/12/2001 | EP1131318A1 Process for making 5-substituted pyrazoles using dithietanes |
| 09/12/2001 | EP1131317A1 Method for preparing (2s)-1- (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide |
| 09/12/2001 | EP1131314A1 Compounds having cytokine inhibitory activity |
| 09/12/2001 | EP1131297A1 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 09/12/2001 | EP1131288A1 Pyrrolidine derivatives-ccr-3 receptor antagonists |